Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Arteriovenous Vascular (AV) ACCESS Trial

NCT: NCT04646226 · ACTIVE_NOT_RECRUITING

NCT IDNCT04646226
StatusACTIVE_NOT_RECRUITING
Start Date2022-08-18
Completion2027-08-31
SponsorWake Forest University Health Sciences (OTHER)
First posted
Last updated

Brief Summary

This study is to prospectively compare the effectiveness and safety of the two types of arteriovenous access placement (fistula or graft) in older adults with end stage kidney disease and multiple chronic conditions

Frequently Asked Questions

What is The Arteriovenous Vascular (AV) ACCESS Trial?

The Arteriovenous Vascular (AV) ACCESS Trial is a clinical trial registered under NCT04646226. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04646226?

The current status of NCT04646226 (The Arteriovenous Vascular (AV) ACCESS Trial) is: ACTIVE_NOT_RECRUITING.

When did The Arteriovenous Vascular (AV) ACCESS Trial start?

The Arteriovenous Vascular (AV) ACCESS Trial started on 2022-08-18.

Related Devices

K252277Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645)Vascular Flow Technologies Limited PMA P060002System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatmentBard Peripheral Vascular PMA P130029System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatmentBard Peripheral Vascular, Inc. PMA P240004Covered stent vascular connector, hemodialysis access circuitPhraxis, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑